(Q56985572)

English

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis

No description defined

In more languages

Statements

scholarly article

0 references

Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis (English)

0 references

liver cirrhosis

0 references

magnetic resonance imaging

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Rita Golfieri

1

0 references

Matteo Renzulli

2

0 references

Vincenzo Lucidi

3

0 references

Beniamino Corcioni

4

0 references

Franco Trevisani

5

0 references

Luigi Bolondi

6

0 references

language of work or name

0 references

publication date

June 2011

0 references

European Radiology

0 references

21

0 references

6

0 references

1233-42

0 references

https://scigraph.springernature.com/pub.10.1007/s00330-010-2030-1

0 references

Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma: recent trends in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Gadobenate dimeglumine (Gd-BOPTA). An overview

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arte

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Detection of hepatocellular carcinoma: value of adding delayed phase imaging to dual-phase helical CT.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Early hepatocellular carcinoma and dysplastic nodules

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

Multistep human hepatocarcinogenesis: correlation of imaging with pathology

1 reference

https://api.crossref.org/works/10.1007%2FS00330-010-2030-1

21 January 2018

The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Terminology of nodular hepatocellular lesions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable surgical outcomes in patients with early hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of early hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascularization of small hepatocellular carcinomas: correlation with differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21293864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00330-010-2030-1

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56985572&oldid=1933759421"